| Dr Keith C Barkow, MD | |
|
851 Parkway Ave, Elkhart, IN 46516-9334 | |
| (574) 537-0521 | |
| (574) 537-1217 |
| Full Name | Dr Keith C Barkow |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 851 Parkway Ave, Elkhart, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891767372 | NPI | - | NPPES |
| 200242310 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01048887A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Goshen Hospital | Goshen, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Goshen Health System Inc | 4880598572 | 132 |
News Archive
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today announced the closing of previously announced agreements to sell $1.25 million of shares of its common stock together with warrants to purchase additional shares of its common stock in a private placement transaction.
DuPont Nutrition & Biosciences scientists have proven their expertise through decades of research and manufacturing excellence to create one of the industry's broadest product portfolios.
Researchers from Queen Mary University of London have developed new cell-based technologies which could help improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.
Based on the results, the researchers led by Dr Melina Arnold from the International Agency for Research on Cancer, estimate that a quarter of all obesity-related cancers in 2012 (118 000 cases) were attributable to the rising average body mass index (BMI) in the population since 1982, and were therefore "realistically avoidable".
› Verified 4 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today announced the closing of previously announced agreements to sell $1.25 million of shares of its common stock together with warrants to purchase additional shares of its common stock in a private placement transaction.
DuPont Nutrition & Biosciences scientists have proven their expertise through decades of research and manufacturing excellence to create one of the industry's broadest product portfolios.
Researchers from Queen Mary University of London have developed new cell-based technologies which could help improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.
Based on the results, the researchers led by Dr Melina Arnold from the International Agency for Research on Cancer, estimate that a quarter of all obesity-related cancers in 2012 (118 000 cases) were attributable to the rising average body mass index (BMI) in the population since 1982, and were therefore "realistically avoidable".
› Verified 4 days ago
| Entity Name | Goshen Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194772293 PECOS PAC ID: 4880598572 Enrollment ID: O20031124000658 |
News Archive
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today announced the closing of previously announced agreements to sell $1.25 million of shares of its common stock together with warrants to purchase additional shares of its common stock in a private placement transaction.
DuPont Nutrition & Biosciences scientists have proven their expertise through decades of research and manufacturing excellence to create one of the industry's broadest product portfolios.
Researchers from Queen Mary University of London have developed new cell-based technologies which could help improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.
Based on the results, the researchers led by Dr Melina Arnold from the International Agency for Research on Cancer, estimate that a quarter of all obesity-related cancers in 2012 (118 000 cases) were attributable to the rising average body mass index (BMI) in the population since 1982, and were therefore "realistically avoidable".
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith C Barkow, MD 226 Us Highway 20, Middlebury, IN 46540-9713 Ph: (574) 825-8068 | Dr Keith C Barkow, MD 851 Parkway Ave, Elkhart, IN 46516-9334 Ph: (574) 537-0521 |
News Archive
Spherix Incorporated – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today announced the closing of previously announced agreements to sell $1.25 million of shares of its common stock together with warrants to purchase additional shares of its common stock in a private placement transaction.
DuPont Nutrition & Biosciences scientists have proven their expertise through decades of research and manufacturing excellence to create one of the industry's broadest product portfolios.
Researchers from Queen Mary University of London have developed new cell-based technologies which could help improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.
Based on the results, the researchers led by Dr Melina Arnold from the International Agency for Research on Cancer, estimate that a quarter of all obesity-related cancers in 2012 (118 000 cases) were attributable to the rising average body mass index (BMI) in the population since 1982, and were therefore "realistically avoidable".
› Verified 4 days ago
Jason J Hix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2310 California Road, Elkhart, IN 46514 Phone: 574-264-4163 Fax: 574-262-9650 | |
Dr. David M Dyck, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 County Road 6 E, Elkhart, IN 46514 Phone: 574-264-9635 Fax: 574-262-0398 | |
Sam Joseph Borrelli, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25651 County Road 20, Elkhart, IN 46517 Phone: 574-522-1201 | |
Saadia Qasim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 County Road 6 E, Elkhart, IN 46514 Phone: 574-264-9635 Fax: 574-262-0398 | |
Dr. Genevieve A Lankowicz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 600 East Blvd, West Wing, Elkhart, IN 46514 Phone: 574-523-2751 Fax: 574-389-4840 | |
Lydia K Mertz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 608 Oakland Ave, Elkhart, IN 46516 Phone: 574-523-2127 Fax: 574-522-2192 | |
Susan Marie Moore-riesbeck, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28070 County Road 24, Elkhart, IN 46517 Phone: 574-273-8053 Fax: 574-273-8056 |